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Adenovirus mutants that lack the entire E4 region are severely defective for late gene expression. E4 mutant genomes are also
concatenated by host double strand break repair (DSBR) proteins. We find that E4 mutant late gene expression improves in MO59J cells that
fail to form genome concatemers. DSBR kinase inhibitors interfere with genome concatenation and also stimulate late gene expression.
Concatenation of E4 mutant genomes interferes with cytoplasmic accumulation of viral late messages and leads to reduced late protein levels
and poor viral yields following high multiplicity infection. However, failure to concatenate viral genomes did not rescue either the DNA
replication defect or virus yield following low multiplicity E4 mutant infection. Our results indicate that if the E4 mutant DNA replication
defect is overcome by high multiplicity infection, concatenation of the replicated genomes by host DSBR interferes with viral late gene
expression.
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Adenovirus (Ad) early region 4 (E4) encodes a diverse
set of proteins that are crucial to a productive lytic
infection. The protein products of E4 open reading frames
3 (E4-11 kDa) and 6 (E4-34 kDa) possess complementary
roles in the efficient onset of viral DNA replication, late
mRNA splicing, and in the accumulation of late mRNAs
and proteins (reviewed in Tauber and Dobner, 2001).
Single mutations affecting either the E4-11 kDa or E4-34
kDa genes have only a modest effect on virus late gene
expression, while mutations affecting both genes result in
more severe late gene expression defects. These results
suggest that the E4-11 kDa and E4-34 kDa proteins are
able to partially compensate for each other’s function
(Bridge and Ketner, 1989; Huang and Hearing, 1989). Ad
mutants that lack the entire E4 region are severely0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: BridgeE@muohio.edu (E. Bridge).defective for late protein synthesis; this defect is attributed
to decreased levels of nuclear and cytoplasmic late RNA
(Bridge and Ketner, 1990; Halbert et al., 1985; Huang and
Hearing, 1989). Although late message levels are reduced,
the transcription rate of viral late genes is close to normal,
suggesting that E4 products might directly or indirectly
stabilize newly synthesized viral late RNA (Sandler and
Ketner, 1989).
Cells infected with E4 mutant viruses produce con-
catenated viral DNA genomes (Boyer et al., 1999; Stracker
et al., 2002; Weiden and Ginsberg, 1994). E4 protein
products prevent genome concatenation by interfering with
the activity of host double strand break repair (DSBR)
proteins. The E4-11 kDa and E4-34 kDa proteins each
form a physical complex with the DSBR enzyme DNA-
dependent protein kinase catalytic subunit (DNA-PKcs)
(Boyer et al., 1999). The E4-34 kDa protein forms a
complex with a viral 55 kDa protein encoded by early
region 1b (E1b-55 kDa); this complex targets DSBR
proteins of the Mre11–Rad50–Nbs1 (MRN) complex for
proteasome-mediated degradation (Stracker et al., 2002).05) 286 – 296
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proteins, preventing them from localizing to sites of viral
replication (Evans and Hearing, 2005; Stracker et al.,
2002). It is possible that E4 proteins promote efficient viral
late gene expression by inhibiting the host cell’s ability to
concatenate viral DNA genomes. Compensatory roles for
the E4-11 kDa and E4-34 kDa proteins in both processes
(Bridge and Ketner, 1989; Stracker et al., 2002) are
consistent with this hypothesis.
Ad genomes are double stranded linear DNA. Infection
by E4 mutants triggers a DNA damage response in host
cells similar to that induced by DNA breaks caused by
ionizing radiation or genotoxic stress (Boyer et al., 1999;
Carson et al., 2003; Stracker et al., 2002). The DNA
damage response leads to activation of DSBR proteins
that are normally involved in repairing double strand
breaks (reviewed in Khanna and Jackson, 2001). DSBR
proteins repair double strand breaks by at least two
distinct mechanisms: homologous recombination and non-
homologous end joining (NHEJ). Members of the Rad52
epistasis group carry out homologous recombination. The
MRN complex is involved in both homologous recombi-
nation and NHEJ. NHEJ is the predominant mode of
DSBR in higher eukaryotes (Allen et al., 2003). A key
component of the NHEJ apparatus is the DNA-PKcs
enzyme. DNA-PKcs belongs to the phosphatidylinositol-3
(PI-3) family of protein kinases that includes the cell cycle
regulators ataxia-telangiectasia mutated (ATM) and ATM-
Rad3-related (ATR) (Smith and Jackson, 1999). Ad E4
mutant infections induce a cellular DNA damage response
with the activation of ATM and ATR (Carson et al.,
2003). These activities affect cell cycle regulation and
apoptosis as well as DNA repair. Thus, preventing the
DNA damage response and the concatenation of viral
DNA may play important roles in a productive Ad
infection.
The concatemers that arise in E4 mutant infections are
covalently linked DNA molecules that are imprecisely
ligated in random head-to-head, head-to-tail, and tail-to-tail
orientation (Weiden and Ginsberg, 1994). Extensive genome
concatenation could destroy viral origins of replication
located at the ends of the linear genome, or produce DNA
molecules too large to be packaged into the viral capsids.
Here, we have tested the hypothesis that genome concate-
nation may also interfere with efficient viral late gene
expression. Our results indicate that an E4 mutant virus
expresses late proteins better in a cell line that lacks the
DSBR enzyme, DNA-PKcs, and hence does not form
genome concatemers. We show that interfering with the
activity of DSBR kinases inhibits E4 mutant genome
concatenation and substantially rescues its late gene
expression defect. Preventing genome concatenation with
DSBR kinase inhibitors stimulates the accumulation of viral
late mRNA. These results suggest that E4 proteins promote
efficient Ad late gene expression, at least in part, by
interfering with genome concatenation.Results
Late protein synthesis of an E4 mutant improves in cells that
fail to concatenate viral genomes
We have investigated the role of genome concatenation
in the late protein defect of E4 mutant H5dl1007 by
comparing viral late gene expression in cell lines that do and
do not form genome concatemers. MO59K and MO59J cells
are derived from a human glioma (Allalunis-Turner et al.,
1993). MO59J cells lack DNA-PKcs and fail to concatenate
E4 mutant genomes, while MO59K cells make normal
levels of DNA-PKcs and efficiently concatenate E4 mutant
viral genomes (Boyer et al., 1999). We assayed viral late
protein production following infection of MO59J and
MO59K cells to assess the role of DNA-PKcs and genome
concatenation in E4 mutant late gene expression. HeLa,
MO59K, and MO59J cells were infected with wild type Ad
serotype 5 (Ad5) or the E4 deletion mutant H5dl1007 at 30
FFU/cell. H5dl1007 is derived from Ad5 and lacks all E4
open reading frames (Bridge and Ketner, 1989). Total cell
extracts were prepared 20–22 h postinfection (hpi) for
Western blot analysis using antiserum against the viral late
proteins penton and fiber (Aspegren et al., 1998). Late
protein levels were quantified by phosphorimaging and the
results are shown in Fig. 1A. H5dl1007 late protein levels
were reduced 10-fold compared to Ad5 in HeLa and
MO59K cells; this result is consistent with previous reports
(Bridge and Ketner, 1989), and demonstrates that H5dl1007
has a similar late gene expression defect in HeLa and
MO59K cells. In contrast, the late protein defect of
H5dl1007 was only 2-fold in MO59J cells (Fig. 1A). The
levels of DNA produced by H5dl1007 were similar to Ad5
in all three cell lines, indicating that a defect in DNA
replication did not contribute to reduced late protein levels
at this multiplicity of infection (data not shown). We
analyzed DNA prepared from Ad5 and H5dl1007 infected
HeLa, MO59K, and MO59J cells at 22 hpi by pulsed field
gel electrophoresis (PFGE) to detect the presence of genome
concatemers. H5dl1007 infections of HeLa and MO59K cell
lines resulted in the production of concatenated genomes
that were not detected in MO59J cells (Fig. 1B), as reported
previously (Boyer et al., 1999). Taken together, these results
indicate that late gene expression of H5dl1007 improves
following infection of a cell line that lacks DNA-PKcs and
is unable to concatenate viral genomes.
Inhibition of DSBR kinases interferes with E4 mutant
genome concatenation and stimulates late gene expression
DNA-PKcs is required for concatenating E4 mutant
virus genomes (Boyer et al., 1999). Interfering with DNA-
PKcs kinase activity is therefore expected to inhibit
genome concatenation. Wortmannin is a fungal metabolite
that covalently binds to a lysine residue in the kinase
domain and irreversibly inhibits DNA-PKcs, thereby
Fig. 2. Inhibition of DSBR kinases interferes with E4 mutant genome
concatenation. HeLa cells (A) or MO59J cells (B) were infected with Ad5
or H5dl1007 and cultured with or without 15 AM wortmannin (wort.) for
32 h. Intracellular DNA was prepared from infected cells for analysis of
genome concatemers by PFGE and Southern blotting. (C) HeLa cells were
infected with Ad5 and H5dl1007 and cultured for 20–22 h with or
without 10 mM caffeine. Intracellular DNA was analyzed by PFGE.
Ethidium bromide staining was used to visualize unit length (36 kbp) and
concatenated Ad genomes.
Fig. 1. E4 mutant late protein synthesis improves in MO59J cells that lack
DNA-PKcs. HeLa, MO59K, and MO59J cells were infected with wild type
Ad5 or E4 deletion mutant H5dl1007 (1007) for 20–24 h. (A) 30 Ag of
total protein was analyzed by Western blotting using a rabbit polyclonal
antiserum against the viral late proteins penton and fiber. Late protein levels
were quantified by phosphorimager analysis. E4 mutant late protein levels
are expressed as the percent of Ad5 levels (set at 100%). Error bars indicate
the standard deviation from three independent experiments performed in
each cell line. (B) Intracellular DNA was prepared from infected cells and
analyzed by PFGE (see Materials and methods). Ethidium bromide staining
was used to visualize unit length (36 kbp) and concatenated Ad genomes.
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studied E4 mutant genome concatenation in infected
cultures treated with wortmannin. HeLa cells were infected
with Ad5 or H5dl1007, and cultured in the presence or
absence of 15 AM wortmannin for 32 h to measure the
effect of this inhibitor on genome concatenation. The
amount of viral DNA concatenation was measured by
PFGE and Southern blotting. As expected, H5dl1007
infection of HeLa cells produced concatemers of at least
six genome lengths. Treatment with wortmannin signifi-
cantly reduced concatenation of H5dl1007 genomes (Fig.
2A). Ad5 produced exclusively monomeric viral DNA
regardless of wortmannin treatment. H5dl1007 genomes
were not concatenated in MO59J cells, as expected (Fig.
2B). Our results suggest that wortmannin interferes with
concatenation of E4 mutant genomes in cell lines with
active DNA-PKcs. Wortmannin did not have a significant
effect on levels of viral DNA in any cell line tested (Fig. 2
and data not shown), indicating that it did not interfere
with Ad DNA replication.Wortmannin affects DNA-PKcs and at high concentra-
tions can also interfere with other PI-3 kinases involved in
DNA damage response signaling, including ATM and ATR
(Sarkaria et al., 1998). ATM and ATR play an important role
in DNA damage-induced arrest at G1/S, S, and G2/M
checkpoints (Kurz and Lees-Miller, 2004; Shechter et al.,
2004). ATM participates in signal transduction following
DNA damage but has not been implicated in genome
concatenation of E4 mutants (Stracker et al., 2002). Caffeine
inhibits both ATM- and ATR-mediated downstream signal-
ing, abolishing the ionizing radiation-induced checkpoint
response (Sarkaria et al., 1999). Caffeine inhibits DNA-
PKcs induced phosphorylation of the 32 kDa subunit of
replication protein A (RPA) in response to DNA damage,
but does not affect DNA-PKcs-mediated NHEJ following
ionizing radiation (Block et al., 2004). We next studied the
effect of caffeine on E4 mutant genome concatenation.
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cultured in the presence or absence of 10 mM caffeine for
20–22 h. Intracellular DNA was then analyzed by PFGE.
We found that caffeine treatment significantly reduced
genome concatenation in H5dl1007 infections (Fig. 2C).
Ad5 produced exclusively monomeric viral DNA regardless
of caffeine treatment. This result suggests a possible role for
ATR, ATM, or another caffeine-sensitive kinase in E4
mutant genome concatenation.
Inhibition of DSBR kinase activity substantially rescues the
late protein defect of an E4 mutant virus
Since inhibiting DSBR kinases with wortmannin or
caffeine affects E4 mutant genome concatenation, we next
investigated the effect of these inhibitors on late gene
expression by H5dl1007. Ad5 and H5dl1007 infected HeLaFig. 3. Inhibition of DSBR kinase activity partially rescues the late protein defect
Ad5, or H5dl1007 and cultured without or without (A) 15 AM wortmannin (wort.)
for the solvent used to dissolve wortmannin (see Western blot shown in part A). We
and fiber (top panels). Late protein levels were quantified as described in Fig. 1, an
performed with the inhibitors wortmannin and caffeine, respectively. The error bars
performed a dose– response experiment by treating H5dl1007 infected HeLa ce
concatemers and levels of late proteins penton and fiber were assessed by PFGE (
were infected with Ad5 or H5dl1007 and cultured with or without 15 AM wortm
penton and fiber were assayed by Western blotting and quantified as described in F
experiments.cells were cultured with or without 15 AMwortmannin, or 10
mM caffeine. Total cell extracts were prepared at 20–22 hpi
for Western blot analysis to compare viral late protein levels.
The results are presented in Fig. 3. H5dl1007 infected HeLa
and MO59K cells showed a 10-fold reduction in late protein
levels compared to Ad5. Treatment with 15 AM wortmannin
(Fig. 3A) or 10 mM caffeine (Fig. 3B) increased E4 mutant
late protein levels by 5- to 7-fold. Late protein levels of Ad5
were not affected by wortmannin or caffeine treatment
indicating that these kinase inhibitors do not have a general
stimulatory effect on Ad late gene expression. We performed
a dose response experiment to further characterize the
relationship between genome concatenation and late protein
levels in the presence of increasing amounts of wortmannin.
Intracellular DNA from HeLa cells infected with H5dl1007
was assayed for the presence of genome concatemers by
PFGE. Total cell extracts from parallel experiments wereof an E4 mutant virus. HeLa cells were either uninfected (UI), infected with
or (B) 10 mM caffeine. DMSO (D) was added to some cultures as a control
stern blot analysis was performed to detect levels of the late proteins penton
d the results are graphed in the lower panels. W and C indicate experiments
indicate the standard deviation from three independent experiments. (C) We
lls with increasing concentrations of wortmannin for 20–22 h. Genome
top panel) or Western blotting (lower panel), respectively. (D) MO59J cells
annin (W) or 10 mM caffeine (C) for 20–22 h. Levels of the late proteins
ig. 1. The error bars indicate the standard deviation from three independent
Fig. 4. The affect of DSBR kinase inhibitors on the DNA damage response
induced by E4 mutant infections. HeLa cells were either uninfected (UI) or
infected with Ad5 or H5dl1007 and cultured with or without 15 AM
wortmannin (W) or 10 mM caffeine (C) for 20–22 h. Cell extracts were
prepared and 50 Ag of total protein was used for Western blot analysis of
(A) phosphorylated Nbs1 and (B) phosphorylated Chk1.
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blotting. PFGE of H5dl1007 infected HeLa cells revealed a
decrease in genome concatenation in the presence of
increasing concentration of wortmannin that correlated with
a simultaneous increase in late protein levels (Fig. 3C). A
similar response was observed to an increasing dose of
caffeine (data not shown). Wortmannin and caffeine also
stimulated H5dl1007 late protein levels following infection
of MO59K cells (data not shown). These results show that
DSBR kinase inhibitors that interfere with E4 mutant
genome concatenation substantially rescue its late gene
expression defect.
We next assayed the ability of wortmannin and caffeine
to induce late gene expression in E4 mutant infections of
MO59J cells. MO59J cells lack functional DNA-PKcs, have
substantially reduced ATM kinase activity (Chan et al.,
1998), and fail to concatenate E4 mutant genomes (Boyer et
al., 1999; Fig. 1). If wortmannin and caffeine promote E4
mutant late gene expression by inhibiting genome concat-
enation, they should not affect E4 mutant late gene
expression in MO59J cells. MO59J cells were infected with
Ad5 and H5dl1007 and cultured in the presence or absence
of 15 AM wortmannin or 10 mM caffeine. Total cell extracts
from Ad5 and H5dl1007 infected MO59J cells were
prepared for Western blot analysis at 20–22 hpi to compare
viral late protein levels. Both DSBR kinase inhibitors failed
to stimulate H5dl1007 late protein levels in MO59J cells
(Fig. 3D) indicating that the increase in E4 mutant late gene
expression seen in HeLa cells (Figs. 3A–C) requires that
cells are able to concatenate viral genomes, or the presence
of functional DNA-PKcs and ATM.
E4 mutants induce a DNA damage response that leads to
the phosphorylation of several cellular proteins (Carson et
al., 2003). Thus, it is possible that treatment with wortman-
nin or caffeine would interfere with cellular damage
response signaling in addition to inhibiting E4 mutant
genome concatenation. We studied the effect of wortmannin
and caffeine treatment on phosphorylation of two cellular
DSBR proteins involved in the damage response, Nbs1 and
Chk1, to assess this possibility. Ad5 and H5dl1007 infected
HeLa cells were cultured in the presence or absence of 15
AM wortmannin, or 10 mM caffeine. Total cell extracts were
prepared at 20–22 hpi for Western blot analysis using an
antibody specific for the phosphorylated form of Nbs1.
Infection with H5dl1007 activated phosphorylation of Nbs1
even following wortmannin and caffeine treatment (Fig.
4A), suggesting that these inhibitors did not prevent this
aspect of the damage response despite their ability to inhibit
Ad genome concatenation. Levels of total Nbs1 were not
affected by E4 mutant infection or treatment with DSBR
kinase inhibitors (data not shown). Ad5 did not activate
phosphorylation of Nbs1 consistent with its failure to
stimulate a damage response (Carson et al., 2003). When
we examined H5dl1007-induced phosphorylation of Chk1,
we found that wortmannin treatment did not interfere with
Chk1 phosphorylation in E4 mutant infected cells, whiletreatment with caffeine reduced the phosphorylation of Chk1
2–3-fold, as shown previously (Carson et al., 2003). Thus,
although both kinase inhibitors interfered with E4 mutant
genome concatenation and stimulated E4 mutant late gene
expression, only caffeine interfered with phosphorylation of
Chk1 during the damage response. These data suggest that
the increase in E4 mutant late gene expression observed
following the inhibition of DSBR kinases is more tightly
correlated with their inhibition of genome concatenation,
rather than the ability to interfere with damage response
signaling.
E4 mutant genome concatenation interferes with viral late
mRNA accumulation
Previous investigations on the late gene expression defect
of E4 mutants suggested that the defect was the result of a
posttranscriptional effect on nuclear RNA stability. A
reduction in nuclear and cytoplasmic steady state mRNA
levels was responsible for the late protein synthesis defect of
E4 mutants (Bridge and Ketner, 1989; Sandler and Ketner,
1989). We have characterized the molecular step at which
late gene expression is stimulated by DSBR kinase
inhibitors. We first determined whether the stimulation of
E4 mutant late gene expression was due to an effect on early
gene expression and/or DNA replication. Ad5 and
H5dl1007 infected HeLa cells were cultured in the presence
or absence of 15 AM wortmannin or 10 mM caffeine to
interfere with genome concatenation and stimulate late gene
expression. Cell extracts were processed at 20–22 hpi for
Western blot analysis with antibodies raised against the
early 72 kDa viral DNA binding protein, or for analysis of
viral DNA. Levels of 72 kDa were similar in H5dl1007 or
Ad5 infected cells and did not change following treatment
with wortmannin (Fig. 5A); identical results were obtained
with caffeine (data not shown). This indicates that the effect
of DSBR kinase inhibitors on late gene expression was at a
step following early gene expression. Southern blotting and
phosphorimaging analysis of EcoRI-digested total DNA
revealed that H5dl1007 accumulated normal levels of viral
DNA compared to Ad5 and the levels did not change
Fig. 6. The DNA replication defect of E4 mutants at low MOI is not rescued
by the failure to concatenate viral genomes. MO59J and MO59K cells were
infected with Ad5 and H5dl1007 at multiplicities of 3 or 30 FFU/cell. At 22
hpi, total intracellular DNA was prepared, digested with EcoRI, and
analyzed by Southern blotting. The EcoRI C fragment is shown.
Fig. 5. E4 mutant genome concatenation interferes with viral late mRNA
accumulation. HeLa cells either uninfected (UI) or infected with Ad5 or
H5dl1007 were cultured with or without 15 AM wortmannin (W) or 10 mM
caffeine (C) for 20–22 h to compare (A) viral early protein levels, (B) viral
DNA levels, and (C) viral late RNA levels. (A) Levels of the early 72 kDa
DNA binding protein were measured by Western blotting. (B) Southern blot
analysis was performed with 10 Ag of EcoRI-digested DNA prepared from
each infection. The Ad EcoRI C fragment used for comparison of viral
DNA levels is shown (top panel). Viral DNA levels were quantified by
phosphorimaging analysis (bottom panel). The E4 mutant DNA levels are
expressed as the percent of Ad5 (set at 100%). The error bars indicate the
average standard deviation from three independent experiments. (C)
Northern analysis was carried out to measure the cytoplasmic levels of
the viral late message for pVI. A representative Northern blot is shown in
the top panel. Viral late RNA levels were quantified by phosphorimaging
analysis. E4 mutant RNA levels are expressed as the percent of Ad5 (set at
100%). The error bars indicate the standard deviation from three
independent experiments.
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This shows that differences in viral DNA levels were not
responsible for the increase in late protein levels induced by
DSBR kinase inhibitors.
We next determined if treatments that interfere with
genome concatenation rescue E4 mutant late message
levels. Cytoplasmic mRNA prepared from H5dl1007 or
Ad5 infected HeLa cells 20–22 hpi was analyzed byNorthern blotting using random primed DNA from the pVI
gene as a probe. The results are shown in Fig. 5C. H5dl1007
pVI mRNA levels were reduced about 13-fold compared
with Ad5, and inhibition of DSBR kinases with 15 AM
wortmannin or 10 mM caffeine increased pVI late message
levels about 7-fold, such that they were within 2-fold of
Ad5. We saw a similar increase in levels of hexon mRNA
following treatment with DSBR kinase inhibitors (data not
shown). These data indicate that inhibitors of genome
concatenation can substantially rescue the late mRNA
accumulation defect of an E4 mutant.
E4 mutant DNA replication and virus yield are severely
reduced at lower multiplicities of infection and are not
rescued by preventing genome concatenation
The experiments described above were performed at an
MOI of 30 FFU/cell; under these infection conditions, E4
mutants replicate their genomes at close to wild type Ad5
levels. However, E4 mutants have a substantial DNA
replication defect at lower MOIs (Halbert et al., 1985;
Weinberg and Ketner, 1986). We next assessed the role of
genome concatenation for E4 mutant DNA replication
following low multiplicity infection. MO59K and MO59J
cells were infected with Ad5 and H5dl1007 at 3 or 30 FFU/
cell and total DNAwas prepared at 24 hpi for Southern blot
analysis. The results in Fig. 6 show that although H5dl1007
DNA levels were comparable to Ad5 at high MOI, they
were substantially reduced at low MOI. Furthermore, the
DNA defect observed following low multiplicity infection
with H5dl1007 was severe in both MO59K and MO59J
cells, despite the inability of the latter to concatenate viral
genomes. This result suggests that the inability of MO59J
cells to concatenate E4 mutant genomes does not rescue the
E4 mutant DNA replication defect observed in low multi-
plicity infections.
Table 1
Virus yield following low and high multiplicity infection of MO59K and
MO59J cells
Cell line MOI = 3 MOI = 30
Ad5 1007 Ad5 1007
MO59K 8  107a 0.0 6  109 2  107
MO59J 8  107 0.0 6  109 3  109
a Virus yield was measured by preparing a freeze/thaw lysate of infected
cells at 48 hpi, and then by determining virus titers on E4-complementing
W162 cells. Virus titers in FFU/ml of the freeze/thaw lysate are shown.
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multiplicity infections of MO59K and MO59J cells to
assess the role of genome concatenation on virus produc-
tion in the presence and absence of a DNA replication
defect. Cells were infected with Ad5 or H5dl1007 at 3 or
30 FFU/cell. A freeze-thaw lysate of the infected cells was
prepared at 48 hpi, and the amount of infectious virus in
each sample was measured by FFU assay (Phillipson,
1961) in W162 cells that complement E4 mutants (Wein-
berg and Ketner, 1983). The results are presented in Table 1.
Following high multiplicity infection of MO59K cells,
H5dl1007 virus yield was reduced about 300-fold. In
contrast, H5dl1007 yield was only reduced about 2-fold in
MO59J cells infected at high MOI. After low multiplicity
infection, Ad5 achieved titers of ¨8  107 FFU/mL in both
MO59K and MO59J cells. In sharp contrast, we failed to
detect infectious E4 mutant virus in lysates prepared from
either cell line infected at low multiplicity. About 80% of
MO59J and MO59K cells express the early 72 kDa
replication protein by 24 hpi following low MOI with
H5dl1007 (data not shown), suggesting that reasonable
levels of infection were achieved. In most of these cells, the
72 kDa protein is diffusely distributed in the nucleus. We
find that less than 5% of the cells have well-developed
replication foci characteristic of viral replication (data not
shown). The resulting severe defect in DNA replication
(Fig. 6) resulted in a profound defect in new virus
production in both cell lines at 48 hpi (Table 1). Previous
work (Bridge and Ketner, 1989) has shown that H5dl1007
eventually produces greatly reduced levels of infectious
virus in plaquing assays, indicating that the block to
replication and new virus production at low MOI is not
absolute. Taken together, our results indicate that failure to
concatenate viral genomes can substantially increase E4
mutant virus yields when the viral replication defect is
alleviated by high multiplicity infection. However, failure to
concatenate viral genomes is insufficient to rescue the E4
mutant DNA replication defect or virus yield following
low MOI.Discussion
E4 mutants are defective for DNA replication and late
gene expression (Halbert et al., 1985; Weinberg andKetner, 1986). Genetic studies have shown that two E4
proteins, E4-34 kDa and E4-11 kDa, can independently
promote efficient viral DNA replication and late gene
expression (Bridge and Ketner, 1989; Huang and Hearing,
1989). Activities of the E4-34 kDa and E4-11 kDa proteins
include the ability to bind, degrade, or redistribute several
host DSBR proteins (Boyer et al., 1999; Stracker et al.,
2002) thereby preventing the concatenation of Ad
genomes. The significance of these E4-mediated activities
on host DSBR for viral growth is under investigation. The
E4-34 kDa protein promotes protein degradation by
forming a complex with protein constituents of an E3
ubiquitin ligase, which then targets selected proteins for
ubiquitination and degradation by the proteasome (Querido
et al., 2001). The ability to form this complex is critical for
the function of E4-34 kDa in complementing E4 mutant
growth (Blanchette et al., 2004). Our previous results
indicate that E4-34 kDa requires active proteasomes for its
ability to promote late gene expression (Corbin-Lickfett
and Bridge, 2003). Recently, Evans and Hearing (2005)
have shown that the function of the E4-11 kDa protein in
promoting viral DNA replication depends on its ability
to redistribute Mre11, and that cells lacking Nbs1 or
Mre11 of the MRN complex complement the growth
defect of an E4 mutant. Taken together, these results
support a model in which inactivation of host DSBR
proteins by either degradation or redistribution is a critical
aspect of the ability of E4 proteins to promote a productive
lytic infection.
E4 mutant genome concatenation requires proteins of
the MRN complex since cell lines lacking either Mre11 or
Nbs1 fail to concatenate E4 mutant genomes (Stracker et
al., 2002). However, the precise effect of genome
concatenation in the virus life cycle is not yet clear.
Shepard and Ornelles (2004) find that growth of an E1b-55
kDa/E4-11 kDa double mutant is defective relative to Ad5
in both MO59J and MO59K cells, suggesting that failure
to concatenate viral genomes was not sufficient to rescue
mutant growth. Furthermore, Evans and Hearing (2003)
have found that the ability of E4-11 kDa to promote viral
replication can be genetically uncoupled from its ability to
prevent viral DNA concatenation. We find that failure to
concatenate E4 mutant genomes substantially rescues its
late gene expression defect following high multiplicity
infections that do not result in a DNA replication defect
(Figs. 1–3). However, E4 mutants have a significant DNA
replication defect relative to Ad5 at low MOI, irrespective
of the cell’s ability to concatenate viral genomes (Fig. 6).
MO59J cells were unable to rescue E4 mutant virus yield
at low MOI (Table 1), and we also find that inhibition of
DSBR with wortmannin did not rescue either the DNA
replication defect or the late gene expression defect of E4
mutants in cells infected at low multiplicity (data not
shown). These results indicate that the DNA replication
defect of E4 mutants is not rescued by the inability of cells
to concatenate viral genomes, and suggest that E4 proteins
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irrespective of genome concatenation. We do not know the
precise role of E4 proteins in promoting DNA replication
at low MOIs. It is possible that, in the absence of E4,
DSBR proteins such as the MRN complex could inactivate
viral genomes even in cells that are unable to complete
genome concatenation. For example, the nuclease activity
of Mre11 could still destroy the viral origin of replication
in MO59J cells that are unable to complete ‘‘repair’’ and
concatenate the viral genome. Alternatively, it is possible
that the expression of other viral early proteins may
compensate for an E4-mediated function in DNA repli-
cation at high MOI.
The DNA replication defect of E4 mutants is alleviated
by high multiplicity infection. However, E4 mutants
display a severe reduction in late gene expression despite
their ability to achieve normal levels of viral DNA (Bridge
and Ketner, 1989). This replication-independent late gene
expression defect is substantially rescued by conditions
that interfere with genome concatenation. E4 mutant late
protein levels and virus yield are within 2-fold of Ad5 in
MO59J cells; this is significantly improved from the
respective 10- and 300-fold defects observed in MO59K
cells that concatenate E4 mutant genomes (Fig. 1 and
Table 1). We also find that the DSBR kinase inhibitors,
wortmannin and caffeine, interfere with genome concate-
nation (Fig. 2) and significantly improve E4 mutant late
protein levels (Fig. 3). DSBR kinase inhibitors could
affect damage response signaling in addition to genome
concatenation. However, Carson et al. (2003) did not see
any effect of wortmannin treatment on E4-mutant induced
phosphorylation of a battery of damage response proteins,
and we did not find that wortmannin affected phosphor-
ylation of either Nbs1 or Chk1 (Fig. 4). Caffeine is a
known inhibitor of damage response signaling by ATM
and ATR (Sarkaria et al., 1999); it inhibits phosphoryla-
tion of Chk1 (Fig. 4B) and was previously shown to
inhibit phosphorylation of several damage response
proteins in E4 mutant infected cells (Carson et al.,
2003). Thus, although wortmannin and caffeine have
different effects on damage response signaling, they have
similar effects on genome concatenation and late gene
expression, suggesting that their ability to stimulate E4
mutant late gene expression is more tightly associated with
inhibition of genome concatenation than with damage
response signaling. Although our data do not rule out the
possibility that wortmannin could stimulate E4 mutant late
gene expression through an as yet untested effect on
damage response signaling, to date our data are most
consistent with a model in which inhibition of genome
concatenation results in increased late gene expression.
Wortmannin and caffeine had no effect on E4 mutant early
gene expression (Fig. 5A) or DNA replication (Fig. 5B),
but did stimulate the accumulation of late mRNA in the
cytoplasm (Fig. 5C). Taken together, these data support
the hypothesis that the DNA-independent defect in latemRNA accumulation exhibited by E4 mutants (Bridge and
Ketner, 1989) can be substantially rescued by preventing
genome concatenation.
E4 mutant late gene transcription has been assayed by
nuclear run-on analysis, and when normalized for the
number of available DNA templates, the transcription rate
is close to that of wild type Ad (Sandler and Ketner, 1989;
Halbert et al., 1985). This suggests that newly synthesized
transcripts from concatenated E4 mutant genomes are less
stable than those produced in cells containing unconcaten-
ated genomes. Why would genome concatenation interfere
with the stability of newly synthesized transcripts? Gene
expression is highly organized in the nuclear compartment
of eukaryotic cells. Transcription and posttranscriptional
processing of mRNA is tightly coordinated, and both
mRNA processing and RNA export factors have been
found to associate with elongating RNA transcripts
(reviewed in Vinciguerra and Stutz, 2004). Concatenation
of viral genomes might interfere with the normal coordina-
tion of transcription, processing and export and result in
decreased nuclear stability of viral mRNA. We have
previously reported that DNA replication centers that form
in cells infected with E4 mutants are often abnormally large,
and contain dense concentrations of the 72 kDa DNA
binding protein (Bridge et al., 2003). Aberrant organization
of concatenated genome templates might prevent proper
access of newly synthesized RNA to processing and export
factors, thereby explaining the reduced stability of E4
mutant late mRNA.
Ad infection exposes a cell to exogenous genetic
material and leads to the activation of cellular DSBR
proteins that usually respond to abnormal and damaged
chromosomal DNA (reviewed by Weitzman et al., 2004).
The activity of DSBR proteins and their effect on the viral
genome may pose a major obstacle to productive Ad
infection that is overcome by viral regulatory proteins
capable of inactivating host DSBR. DSBR could potentially
interfere with viral activities at several steps in the virus life
cycle. When Mre11 localizes to sites of E4 mutant DNA
replication (Stracker et al., 2002), its nuclease activity
could render the ends of Ad genomes incapable of initiating
replication. We have found that Mre11 still localizes to E4
mutant replication centers in MO59J cells that lack DNA-
PKcs and fail to form genome concatemers (data not
shown). Thus, it is possible that the severe DNA replication
defect we see following low multiplicity infection of either
MO59J or MO59K cells (Fig. 6) stems from the activity of
Mre11 on E4 mutant genomes. We show here that even if
E4 mutant viral DNA is replicated, genome concatenation
by host DSBR still interferes with the subsequent accumu-
lation of viral late mRNA. Genome concatenation could
also interfere with virion assembly and packaging. The
ability of Ad to inactivate host DSBR is thus a critical
aspect of establishing a productive infection, and provides
an important new avenue for investigating virus host
interactions.
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Cells and viruses
HeLa and E4 mutant-complementing W162 (Weinberg
and Ketner, 1983) monolayer cell cultures were maintained
in Dulbecco’s Modified Eagle Medium (DMEM) supple-
mented with 10% fetal bovine serum (FBS), 2 mM l-
glutamine, 10 U/mL penicillin, and 10 Ag/mL streptomycin.
MO59J and MO59K cells were provided by Gary Ketner
(Boyer et al., 1999), and were maintained in DMEM with
Ham’s F12 (1:1 mix) supplemented with 10 U/mL
penicillin, 10 Ag/mL streptomycin, 0.5 mM sodium
pyruvate, 0.1 mM nonessential amino acids (GIBCO),
and 10% FBS. Wild type Ad5 and E4 mutant H5dl1007
(Bridge and Ketner, 1989) were propagated on W162 cells.
Ad5 and H5dl1007 virus titers were determined in W162
cells, and expressed as fluorescence forming units (FFU)/
mL (Phillipson, 1961). Cells were infected with 30 FFU/
cell unless otherwise indicated.
DSBR kinase inhibitors
Wortmannin (Sigma-Aldrich) was dissolved in DMSO
and added 2 hpi to a final concentration of 15 AM, for the
times indicated. Caffeine (Sigma-Aldrich) was dissolved in
water and added to the culture 2 hpi to a final concentration
of 10 mM, for the times indicated.
Western blotting analysis
Infected or uninfected cells (¨5  105) seeded in 35
mm dishes were washed twice with ice cold phosphate
buffered saline (PBS) and then lysed in 300 AL of lysis
buffer (150 mM NaCl, 50 mM Tris pH 8.0, 5 mM EDTA,
0.15% (vol/vol) Nonidet P-40, 0.1 mM DTT, and 5 Ag/
mL aprotinin and leupeptin). Cell lysates were sonicated
and total protein levels were measured by Bradford assay
using Coomassie plus protein reagent (Pierce) according
to the manufacturer’s specifications. Equal amounts of
total protein were subjected to sodium dodecylsulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) using 8%
or 12% polyacrylamide gels. Proteins were transferred to
enhanced chemiluminescence (ECL) nitrocellulose (Amer-
sham Pharmacia) overnight and the membranes were
probed with primary antibodies diluted in 5% nonfat dry
milk. Rabbit polyclonal antiserum to the late proteins
penton and fiber (from U. Pettersson) was used at a
1:1000 dilution. Monoclonal antibody B610 (A. Levine)
was diluted 1:100 to detect the early DNA binding protein
E2-72 kDa. Rabbit polyclonal antibody to phosphorylated
Nbs1 (ab15088 from Abcam) was used at a 1:1000
dilution. Rabbit polyclonal antibody to phosphorylated
Chk-1 (a phospho-Chk1(S345) from Cell Signaling) was
diluted 1:1000 into 5% bovine serum albumin and
incubated overnight. Protein blots were incubated with a1:1500 dilution of horseradish-peroxidase conjugated goat
anti-rabbit or anti-mouse IgG secondary antibodies in
5% nonfat dry milk. Proteins were visualized by incubat-
ing blots with ECL reagent and the chemiluminescent
signals were captured using hyperfilm ECL (Amersham
Pharmacia). For phosphorimaging analysis of proteins, a
1:2000 dilution of alkaline phosphatase conjugated goat
anti-rabbit or anti-mouse IgG secondary antibody (Sigma-
Aldrich) was used with enhanced chemifluorescence
(ECF) substrate (Amersham) for detection on a STORM
860 phosphorimager (Molecular Dynamics). Scanned
images were analyzed using ImageQuant\ 5.2 (Molec-
ular Dynamics) software to quantify the amount of
protein.
Viral DNA analysis
Total DNA was isolated from ¨5  105 infected or
uninfected cells as described (Bridge and Ketner, 1989).
10 Ag of total DNA from each sample was digested with
EcoRI and subjected to electrophoresis through a 1%
agarose gel. DNA was transferred to Hybond-N nylon
membrane (Amersham) according to the manufacturer’s
specifications and used for Southern blotting. A 32P-
labeled probe was synthesized from Ad genomic DNA
using the multiprime DNA labeling system (Amersham).
Hybridization with 5  106 cpm/mL was performed at
65 -C for 20 h as described (Sambrook et al., 1989).
Levels of viral DNA were quantified by phosphorimaging
analysis. Scanned images were analyzed using Image-
Quant\ 5.2 (Molecular Dynamics) software to quantify
the amount of DNA.
Pulsed-field gel electrophoresis
Intracellular DNA was prepared and analyzed for the
presence of genome concatemers as previously described
(Boyer et al., 1999). Agarose plugs containing DNA from
¨1.25  105 cells were loaded onto 1.2% agarose gels for
electrophoresis using a CHEF-DR II pulsed field electro-
phoresis system in hexagonal field mode for 10 h at 6 V/cm
with a switch time of 15 s. Gels were stained with ethidium
bromide for visualization of viral DNA concatemers. In
some experiments, gels were further analyzed by Southern
blotting as described above.
Viral RNA analysis
Total cytoplasmic RNA was isolated from ¨5  105
cells and used for Northern blot analysis (Sambrook et al.,
1989). 10 Ag of total RNA from each sample was
fractionated on a 2.2% formaldehyde-1% agarose gel.
The RNA was then transferred to Hybond-N nylon
membrane (Amersham) according to the manufacturer’s
specifications and probed with 32P-labeled pVI DNA. The
pVI probe was prepared by PCR amplification of the pVI
S. Jayaram, E. Bridge / Virology 342 (2005) 286–296 295gene from Ad2 DNA using pVI forward primer corre-
sponding to 5VCAA CTT TGC GTC TCT GGC3V, and a
reverse primer corresponding to 5V CTG TTC AGT GTG
CTT TGC 3V (GenBank accession number BK000408;
Davison et al., 2003). The pVI PCR product was pooled,
purified, and used for random priming with the multiprime
DNA labeling system (Amersham). Hybridization was
performed at 65 -C for 20 h as described (Sambrook et
al., 1989). The amount of cytoplasmic RNA was measured
by phosphorimaging analysis. Scanned images were ana-
lyzed using ImageQuant\ 5.2 (Molecular Dynamics) soft-
ware to quantify the amount of RNA.Acknowledgments
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